Cargando…
The novel lncRNA PTTG3P is downregulated and predicts poor prognosis in non-small cell lung cancer
INTRODUCTION: Lung cancer is the leading cause of cancer-associated mortality worldwide. Recently, long non-coding RNAs (lncRNAs) have been studied as key regulators in some biological processes. Of note, the molecular mechanism and prognostic value of lncRNAs in non-small cell lung cancer (NSCLC) h...
Autores principales: | Huang, Hai-Tao, Xu, Yi-Ming, Ding, Sheng-Guang, Yu, Xiao-Qiang, Wang, Fei, Wang, Hai-Feng, Tian, Xue, Zhong, Chong-Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286322/ https://www.ncbi.nlm.nih.gov/pubmed/32542097 http://dx.doi.org/10.5114/aoms.2020.93535 |
Ejemplares similares
-
LncRNA MEG3 acts a biomarker and regulates cell functions by targeting ADAR1 in colorectal cancer
por: Wang, Wei, et al.
Publicado: (2019) -
Downregulation of lncRNA SDPR-AS is associated with poor prognosis in renal cell carcinoma
por: Ni, Wenjun, et al.
Publicado: (2017) -
PTTG1 expression is associated with hyperproliferative disease and poor prognosis in multiple myeloma
por: Noll, Jacqueline E., et al.
Publicado: (2015) -
PTTG3P promotes gastric tumour cell proliferation and invasion and is an indicator of poor prognosis
por: Weng, Weiwei, et al.
Publicado: (2017) -
High Expression of Pseudogene PTTG3P Indicates a Poor Prognosis in Human Breast Cancer
por: Lou, Weiyang, et al.
Publicado: (2019)